RSC Drug Discovery Series, volume 2017-January, issue 57, pages 51-74

Testing of Geroprotectors in Experiments on Cell Cultures: Pros and Cons

Publication typeBook Chapter
Quartile SCImago
Q4
Quartile WOS
Impact factor
ISSN20413203, 20413211
Abstract
The chapter is a critical review of various approaches to testing of geroprotectors (anti-aging compounds or physical factors) in experiments on cultured cells. The most popular cytogerontological models are reviewed with a focus on general gerontological definitions (aging, cell senescence, biomarkers of aging, aging and non-aging organisms, geroprotectors, age-related diseases, etc.). Among the model systems are the Hayflick model, the stationary phase aging model, and the cell kinetics model. Most attention has been paid to methodological aspects of the testing of geroprotectors with these models. Questions arising when constructing survival curves for cultured cells in the “stationary phase aging” model are analyzed. In particular, consideration is given to some problems encountered when using the most widespread molecular probes designed for live/dead cell viability assays. A note is made that the evaluation of colony-forming efficiency, though optimal for cell viability assessment, is unfortunately not applicable to postmitotic or very slowly propagating cells. Some questions regarding the interpretation of data obtained in such studies in application to humans are also considered. Popular approaches to choosing biomarkers of cell aging/senescence are briefly reviewed. It is assumed that the least number of problems associated with interpreting the results of testing potential geroprotectors in cytogerontological experiments arise when such studies are performed using normal human cells in the model of stationary phase aging, which is based on the concept of cell proliferation restriction as the main cause of accumulation of macromolecular lesions in cells of multicellular organisms with age. However, in the authors' opinion, even this approach will not give the final answer to the question of whether or not the studied factor is a geroprotector. Answering this question will inevitably require both “classic” gerontological experiments in animals and clinical trials.

Citations by journals

1
2
Vestnik Moskovskogo universiteta. Seriya 16. Biologiya
Vestnik Moskovskogo universiteta. Seriya 16. Biologiya, 2, 33.33%
Vestnik Moskovskogo universiteta. Seriya 16. Biologiya
2 publications, 33.33%
Biochemistry (Moscow)
Biochemistry (Moscow), 2, 33.33%
Biochemistry (Moscow)
2 publications, 33.33%
Cell Biochemistry and Function
Cell Biochemistry and Function, 1, 16.67%
Cell Biochemistry and Function
1 publication, 16.67%
Moscow University Biological Sciences Bulletin
Moscow University Biological Sciences Bulletin, 1, 16.67%
Moscow University Biological Sciences Bulletin
1 publication, 16.67%
1
2

Citations by publishers

1
2
3
Pleiades Publishing
Pleiades Publishing, 3, 50%
Pleiades Publishing
3 publications, 50%
Moscow University Press
Moscow University Press, 2, 33.33%
Moscow University Press
2 publications, 33.33%
Wiley
Wiley, 1, 16.67%
Wiley
1 publication, 16.67%
1
2
3
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Khokhlov A. N., Morgunova G. V. Testing of Geroprotectors in Experiments on Cell Cultures: Pros and Cons // RSC Drug Discovery Series. Vol. 2017-January. No. 57. pp. 51-74.
GOST all authors (up to 50) Copy
Khokhlov A. N., Morgunova G. V. Testing of Geroprotectors in Experiments on Cell Cultures: Pros and Cons // RSC Drug Discovery Series. Vol. 2017-January. No. 57. pp. 51-74.
RIS |
Cite this
RIS Copy
TY - GENERIC
DO - 10.1039/9781782626602-00051
UR - https://doi.org/10.1039%2F9781782626602-00051
TI - Testing of Geroprotectors in Experiments on Cell Cultures: Pros and Cons
T2 - RSC Drug Discovery Series
AU - Khokhlov, Alexander N
AU - Morgunova, Galina V
PB - Royal Society of Chemistry (RSC)
SP - 51-74
IS - 57
VL - 2017-January
SN - 2041-3203
SN - 2041-3211
ER -
MLA
Cite this
MLA Copy
Khokhlov, Alexander N., and Galina V Morgunova. “Testing of Geroprotectors in Experiments on Cell Cultures: Pros and Cons.” RSC Drug Discovery Series, vol. 2017-January, no. 57, Apr. 2024, pp. 51-74. https://doi.org/10.1039%2F9781782626602-00051.
Found error?